Liabilities, Current of FibroBiologics, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: FibroBiologics, Inc. quarterly Liabilities, Current in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
FibroBiologics, Inc. Liabilities, Current for the quarter ending 31 Dec 2025 was $1,759,000, a 86% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

FibroBiologics, Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$1,759,000	-$10,967,000	-86%	31 Dec 2025	10-K	24 Feb 2026	2025	FY
Q3 2025	$6,722,000	+$45,000	+0.67%	30 Sep 2025	10-Q	31 Oct 2025	2025	Q3
Q2 2025	$10,964,000	+$832,000	+8.2%	30 Jun 2025	10-Q	31 Jul 2025	2025	Q2
Q1 2025	$8,211,000	-$5,774,000	-41%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$12,726,000	+$3,543,000	+39%	31 Dec 2024	10-K	24 Feb 2026	2025	FY
Q3 2024	$6,677,000			30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$10,132,000			30 Jun 2024	10-Q	07 Aug 2024	2024	Q2
Q1 2024	$13,985,000			31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$9,183,000	+$2,110,000	+30%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q4 2022	$7,073,000			31 Dec 2022	10-K	29 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.